Richard Paulson

2021

In 2021, Richard Paulson earned a total compensation of $8.4M as President and Chief Executive Officer at Karyopharm Therapeutics.

Compensation breakdown

Bonus$300,000
Non-Equity Incentive Plan$435,500
Option Awards$3,563,575
Salary$468,365
Stock Awards$3,523,008
Other$64,724
Total$8,355,172

Paulson received $3.6M in option awards, accounting for 43% of the total pay in 2021.

Paulson also received $300K in bonus, $435.5K in non-equity incentive plan, $468.4K in salary, $3.5M in stock awards and $64.7K in other compensation.

Rankings

In 2021, Richard Paulson's compensation ranked 1,365th out of 12,415 executives tracked by ExecPay. In other words, Paulson earned more than 89.0% of executives.

ClassificationRankingPercentile
All
1,365
out of 12,415
89th
Division
Manufacturing
490
out of 5,501
91st
Major group
Chemicals And Allied Products
179
out of 2,371
93rd
Industry group
Drugs
149
out of 2,092
93rd
Industry
Pharmaceutical Preparations
98
out of 1,542
94th
Source: SEC filing on April 8, 2022.

Paulson's colleagues

We found five more compensation records of executives who worked with Richard Paulson at Karyopharm Therapeutics in 2021.

2021

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2021

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2021

Michael Mason

Karyopharm Therapeutics

Chief Financial Officer

2021

Jatin Shah

Karyopharm Therapeutics

Chief Medical Officer

2021

Ran Frenkel

Karyopharm Therapeutics

Executive Vice President, Chief Development Officer

News

You may also like